| Breanna Kilmartin, MSW | |
|
1001 S Knik Goose Bay Rd, Wasilla, AK 99654-8083 | |
| (907) 631-6100 | |
| Not Available |
| Full Name | Breanna Kilmartin |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 1001 S Knik Goose Bay Rd, Wasilla, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720679046 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Entity Name | Alaska Native Tribal Health Consortium |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772 |
News Archive
Cyanide poisoning is often fatal and typically affects victims of industrial accidents, terrorist attacks, or structural fires. Based on research conducted at the Center for Drug Design at the University of Minnesota, startup Vytacera Pharma Inc. will develop and market Sulfanegen, a treatment for cyanide poisoning. Sulfanegen could be administered by first responders in the case of a mass casualty emergency, or to victims of smoke inhalation from a house fire.
A rule published Wednesday exempts low-income people from the health law's requirement to buy insurance if they live in states that decide against expanding Medicaid. News outlets also report on the latest related developments from Ohio, New Hampshire, Minnesota, Oklahoma and California.
Life Technologies Corporation today announced a series of new product innovations across the company's DNA sequencing portfolio. To date, most sequencing technologies have primarily addressed the needs of researchers in the highest throughput laboratories, limiting widespread accessibility of these powerful next-generation sequencing technologies.
Familial risk for psychosis does not account for the association between abuse during childhood and the later development of schizophrenia, a study suggests.
Researchers funded by the National Institutes of Health have launched an effort to evaluate drugs prescribed to treat COVID-19 in infants, children and adolescents across the country. The study leverages an existing clinical trial that examines drugs that are prescribed off-label to children for a variety of medical conditions.
› Verified 6 days ago
| Entity Name | Southcentral Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780614263 PECOS PAC ID: 5496663627 Enrollment ID: O20051027000416 |
News Archive
Cyanide poisoning is often fatal and typically affects victims of industrial accidents, terrorist attacks, or structural fires. Based on research conducted at the Center for Drug Design at the University of Minnesota, startup Vytacera Pharma Inc. will develop and market Sulfanegen, a treatment for cyanide poisoning. Sulfanegen could be administered by first responders in the case of a mass casualty emergency, or to victims of smoke inhalation from a house fire.
A rule published Wednesday exempts low-income people from the health law's requirement to buy insurance if they live in states that decide against expanding Medicaid. News outlets also report on the latest related developments from Ohio, New Hampshire, Minnesota, Oklahoma and California.
Life Technologies Corporation today announced a series of new product innovations across the company's DNA sequencing portfolio. To date, most sequencing technologies have primarily addressed the needs of researchers in the highest throughput laboratories, limiting widespread accessibility of these powerful next-generation sequencing technologies.
Familial risk for psychosis does not account for the association between abuse during childhood and the later development of schizophrenia, a study suggests.
Researchers funded by the National Institutes of Health have launched an effort to evaluate drugs prescribed to treat COVID-19 in infants, children and adolescents across the country. The study leverages an existing clinical trial that examines drugs that are prescribed off-label to children for a variety of medical conditions.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Breanna Kilmartin, MSW 6129 N Canidae Pl, Wasilla, AK 99654-9418 Ph: (907) 982-7564 | Breanna Kilmartin, MSW 1001 S Knik Goose Bay Rd, Wasilla, AK 99654-8083 Ph: (907) 631-6100 |
News Archive
Cyanide poisoning is often fatal and typically affects victims of industrial accidents, terrorist attacks, or structural fires. Based on research conducted at the Center for Drug Design at the University of Minnesota, startup Vytacera Pharma Inc. will develop and market Sulfanegen, a treatment for cyanide poisoning. Sulfanegen could be administered by first responders in the case of a mass casualty emergency, or to victims of smoke inhalation from a house fire.
A rule published Wednesday exempts low-income people from the health law's requirement to buy insurance if they live in states that decide against expanding Medicaid. News outlets also report on the latest related developments from Ohio, New Hampshire, Minnesota, Oklahoma and California.
Life Technologies Corporation today announced a series of new product innovations across the company's DNA sequencing portfolio. To date, most sequencing technologies have primarily addressed the needs of researchers in the highest throughput laboratories, limiting widespread accessibility of these powerful next-generation sequencing technologies.
Familial risk for psychosis does not account for the association between abuse during childhood and the later development of schizophrenia, a study suggests.
Researchers funded by the National Institutes of Health have launched an effort to evaluate drugs prescribed to treat COVID-19 in infants, children and adolescents across the country. The study leverages an existing clinical trial that examines drugs that are prescribed off-label to children for a variety of medical conditions.
› Verified 6 days ago
Miss Robin Bayard Hughes, LMSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1363 W Spruce Ave, Wasilla, AK 99654 Phone: 907-376-2411 Fax: 907-352-3363 | |
Mary S Grasmick, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1981 E Palmer Wasilla Hwy Ste 200, Wasilla, AK 99654 Phone: 907-802-2493 | |
Ms. Kim-sandy Kline, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4900 E Palmer Wasilla Hwy, Suite 120, Wasilla, AK 99654 Phone: 907-982-2146 | |
Amanda Mae Rose, MSSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3223 E Palmer Wasilla Hwy Ste 4, Wasilla, AK 99654 Phone: 907-631-6300 | |
Dr. Ann Marie Yaros, PH.D. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1261 S Seward Meridian Rd, Wasilla, AK 99654 Phone: 907-357-7550 | |
Lorelei Crewdson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1363 W Spruce Ave, Wasilla, AK 99654 Phone: 907-352-3252 | |
Isaac Dine'h Winters, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 301 E Danna Ave, Wasilla, AK 99654 Phone: 907-357-7519 |